Terms: = Ovarian cancer AND MUC16, CA125, CA-125 AND Staging
245 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
3. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
4. [Study on the predictive significance of PLR, SII and RPR in ovarian endometriotic cyst].
Li MM; Tang XH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):672-679. PubMed ID: 37724384
[No Abstract] [Full Text] [Related]
5. [
Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
[TBL] [Abstract] [Full Text] [Related]
6. Correlations between endometriosis, lipid profile, and estrogen levels.
Zheng R; Du X; Lei Y
Medicine (Baltimore); 2023 Jul; 102(29):e34348. PubMed ID: 37478235
[TBL] [Abstract] [Full Text] [Related]
7. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract] [Full Text] [Related]
8. Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.
Xue B; Wang X
Sci Rep; 2023 Jun; 13(1):9439. PubMed ID: 37296189
[TBL] [Abstract] [Full Text] [Related]
9. Could uterine conservation be an option in presumed early-stage epithelial ovarian cancer?
Benoit L; Pajot C; Koual M; Nguyen-Xuan HT; Bentivegna E; Bats AS; Azaïs H
Arch Gynecol Obstet; 2023 Sep; 308(3):953-960. PubMed ID: 37031304
[TBL] [Abstract] [Full Text] [Related]
10. The Utility of Preoperative Serum ca125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial cancer.
Prueksaritanond N; Angsathapon S; Insin P
Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
[TBL] [Abstract] [Full Text] [Related]
11. Successful pregnancy via in vitro fertilization in a primary infertile woman with primary lymphoma of the fallopian tube after surgery: A case report and literature review.
Zhang J; Hou Z; Huang J; Xu W; Wang C; Ma X; Lu N; Liu J; Mao Y; Qian Y
Medicine (Baltimore); 2022 Jul; 101(30):e29353. PubMed ID: 35905233
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
13. The importance of the Peritoneal cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Rawert FL; Luengas-Würzinger V; Claßen-Gräfin von Spee S; Baransi S; Schuler E; Carrizo K; Dizdar A; Mallmann P; Lampe B
Arch Gynecol Obstet; 2022 Nov; 306(5):1665-1672. PubMed ID: 35357582
[TBL] [Abstract] [Full Text] [Related]
14. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract] [Full Text] [Related]
15. Intense 68Ga-FAPI-46 Activity in Lesions of Recurrent ovarian Clear Cell Carcinoma That Were Negative on FDG PET/CT Study.
Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Chotipanich C
Clin Nucl Med; 2022 Feb; 47(2):e210-e212. PubMed ID: 35006122
[TBL] [Abstract] [Full Text] [Related]
16. Nomogram for predicting postoperative cancer-specific early death in patients with epithelial ovarian cancer based on the SEER database: a large cohort study.
Zhang T; Zhu L
Arch Gynecol Obstet; 2022 Jun; 305(6):1535-1549. PubMed ID: 34841445
[TBL] [Abstract] [Full Text] [Related]
17. Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of ovarian cancer.
Li L; Chen F; Lin A; Wang D; Shi Y; Chen G
Comput Math Methods Med; 2021; 2021():4854282. PubMed ID: 34721658
[TBL] [Abstract] [Full Text] [Related]
18. Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising ca125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Trédan O; Provansal M; Abdeddaim C; Lardy-Cleaud A; Hardy-Bessard AC; Kalbacher E; Floquet A; Venat-Bouvet L; Lortholary A; Pop O; Frenel JS; Cancel M; Largillier R; Louvet C; You B; Zannetti A; Anota A; Treilleux I; Pissaloux D; Houlier A; Savoye AM; Mouret-Reynier MA; Meunier J; Levaché CB; Brocard F; Ray-Coquard I
Gynecol Oncol; 2022 Jan; 164(1):18-26. PubMed ID: 34696892
[TBL] [Abstract] [Full Text] [Related]
19. Factors associated with the involvement of lymph nodes in low-grade serous ovarian cancer.
Durmuş Y; Meydanlı MM; Akıllı H; Kayıkçıoğlu F; Güngördük K; Akbayır Ö; Taşkın S; Çelik H; Ayhan A
J Surg Oncol; 2022 Feb; 125(2):264-272. PubMed ID: 34610148
[TBL] [Abstract] [Full Text] [Related]
20. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
[TBL] [Abstract] [Full Text] [Related]
[Next]
